Here, we examined whether the NRF2 antioxidant pathway could contribute to the increased oxidative damage detected in this disease, in both the Abcd1− mouse model and the skin fibroblasts derived from X‐ALD patients. The gene discussed is NFE2L2; the disease is adrenoleukodystrophy.